Skip to main content

Evgen Pharma "very busy" at start of "exciting year"

Evgen Pharma PLC (AIM:EVG) CEO Dr Huw Jones speaks to Proactive from the sidelines of the BIO International Convention in Boston, MA, following the release of final results for the year to 31st March 2023. Dr Jones gives his take on how the business performed over the twelve months, before moving on to talk about what the current year has in store. He says the clinical stage drug development company is "very busy" at the start of an "exciting year." He also thanks outgoing chief financial officer Richard Moulsen for his contribution to the company.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.